Nouveau Life Pharmaceuticals Inc
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and ar… Read more
Market Cap & Net Worth: Nouveau Life Pharmaceuticals Inc (NOUV)
Nouveau Life Pharmaceuticals Inc (PINK:NOUV) has a market capitalization of $666.10K ($666.10K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #51274 globally and #16001 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nouveau Life Pharmaceuticals Inc's stock price $0.00 by its total outstanding shares 6660963733 (6.66 Billion).
Nouveau Life Pharmaceuticals Inc Market Cap History: 2015 to 2025
Nouveau Life Pharmaceuticals Inc's market capitalization history from 2015 to 2025. Data shows change from $2.00 Million to $666.10K (-10.98% CAGR).
Nouveau Life Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nouveau Life Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NOUV by Market Capitalization
Companies near Nouveau Life Pharmaceuticals Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Nouveau Life Pharmaceuticals Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
Nouveau Life Pharmaceuticals Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Nouveau Life Pharmaceuticals Inc's market cap moved from $2.00 Million to $ 666.10K, with a yearly change of -10.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $666.10K | 0.00% |
| 2024 | $666.10K | -66.67% |
| 2023 | $2.00 Million | 0.00% |
| 2022 | $2.00 Million | -80.00% |
| 2021 | $9.99 Million | +650.00% |
| 2020 | $1.33 Million | -33.33% |
| 2019 | $2.00 Million | -78.57% |
| 2018 | $9.33 Million | +600.00% |
| 2017 | $1.33 Million | -33.33% |
| 2016 | $2.00 Million | 0.00% |
| 2015 | $2.00 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Nouveau Life Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $666.10K USD |
| MoneyControl | $666.10K USD |
| MarketWatch | $666.10K USD |
| marketcap.company | $666.10K USD |
| Reuters | $666.10K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.